Metric Finance
LearnFAQ
LearnFAQ

Learn / IMTX

NASDAQ: IMTX

Immatics N.V. (IMTX) stock, explained like you're 5

Immatics N.V. trades on the Nasdaq under the ticker IMTX. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.1 billion dollars.

Ticker
IMTX
Exchange
Nasdaq
Sector
Healthcare
Industry
Biological Products (No Diagnostic Substances)
Size
Small cap, about 1.1 billion dollars

Is Immatics N.V. a small, medium or large cap company?

No. Immatics N.V. is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Immatics N.V. makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves IMTX stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Immatics (NASDAQ:IMTX) Stock Price Up 4.8% Should You Buy? (MarketBeat)
  • IMTX Initiates Coverage On Stifel Rating Set to Buy with $15 Price Target (GuruFocus)
  • Immatics (IMTX) Stock Dropped, So What Is Driving Attention Now? (Simply Wall Street)
  • Immatics: PRAME Is Becoming More Than A Single Asset Story (NASDAQ:IMTX) (Seeking Alpha)
  • IMTX Forecast Price Target Prediction for 2027 (TradingView)

Follow IMTX in your daily brief

Each trading day at 5 PM ET we post what happened to Immatics N.V. and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow IMTX

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Immatics N.V. stock

What does Immatics N.V. do?

Immatics N.V. trades on the Nasdaq under the ticker IMTX. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.1 billion dollars.

What is the ticker symbol for Immatics N.V.?

Immatics N.V. trades under the ticker IMTX on the Nasdaq.

What is Immatics N.V.'s market cap?

Immatics N.V. is a small cap stock with a market cap of about 1.1 billion dollars.

How does Immatics N.V. make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves IMTX stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow IMTX stock every day?

Add IMTX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow IMTX daily

A free brief on Immatics N.V. and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ARGX · Argenx SE
  • RVMD · Revolution Medicines
  • BNTX · BioNTech SE
  • EXEL · Exelixis

Similar stocks

  • ARGXArgenx SE
  • RVMDRevolution Medicines
  • BNTXBioNTech SE
  • EXELExelixis

Compare IMTX: IMTX vs ARGX, IMTX vs RVMD, IMTX vs BNTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed